CFTR and cystic fibrosis: These findings are in support of a recent publication in which MDMs isolated from CF patients taking clinical ivacaftor had improved B. cenocepecia phagocytosis and CFTR expression compared to MDMs isolated from CF patients who were taking ivacaftor/lumacaftor50.